YM-90K (hydrochloride hydrate)

YM-90K (hydrochloride hydrate) Suppliers list
Company Name: ChemeGen  
Tel: 18818260767
Email: 2625930290@qq.com
Products Intro: Product Name:YM-90K hydrochloride hydrate
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
Company Name: Cayman Chemical Company  
Tel: 800-364-9897
Email: sales@caymanchem.com
Products Intro: Product Name:YM-90K (hydrochloride hydrate)
Company Name: Neobioscience Co., Ltd.  
Tel: 4006-800-892
Email: info@neobioscience.com
Products Intro: Product Name:YM-90K (hydrochloride hydrate)
Company Name: Guangzhou Qiansheng Biotechnology Co., Ltd.  
Tel: 14748676110
Email:
Products Intro: Product Name:YM-90K (hydrochloride hydrate)
YM-90K (hydrochloride hydrate) Basic information
Product Name:YM-90K (hydrochloride hydrate)
Synonyms:YM-90K (hydrochloride hydrate)
CAS:
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
YM-90K (hydrochloride hydrate) Structure
YM-90K (hydrochloride hydrate) Chemical Properties
solubility DMSO: 5 mg/ml
Safety Information
MSDS Information
YM-90K (hydrochloride hydrate) Usage And Synthesis
DescriptionYM-90K is an AMPA receptor antagonist (Ki = 0.084 μM in a radioligand binding assay using rat brain membranes).1 It is selective for AMPA over kainate, NMDA-sensitive glutamate, and strychnine-insensitive glycine receptors (Kis = 2.2, >100, and 37 μM, respectively). Intrastriatal administration of YM-90K inhibits AMPA-induced decreases in choline acetyltransferase (ChAT) activity in rat striatum ex vivo in a dose-dependent manner. It inhibits audiogenic seizures in susceptible DBA/2 mice with a minimum effective dose of 3 mg/kg when administered intraperitoneally. Intravenous infusion of YM-90K (20 mg/kg per hour for 4 hours) reduces infarct size in a rat model of focal cerebral ischemia induced by thrombotic middle cerebral artery occlusion (MCAO) in rats.2WARNING This product is not for human or veterinary use.
References[1] J. OHMORI. 6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: structure-activity relationships for the AMPA-type non-NMDA receptor[J]. Journal of Medicinal Chemistry, 1994, 37 4: 467-475. DOI: 10.1021/jm00030a006
[2] K UMEMURA  M N  A Shimakura. Neuroprotective effect of a novel AMPA receptor antagonist, YM90K, in rat focal cerebral ischaemia[J]. Brain Research, 1997, 773 1: Pages 61-65. DOI: 10.1016/s0006-8993(97)00894-9
YM-90K (hydrochloride hydrate) Preparation Products And Raw materials
Tag:YM-90K (hydrochloride hydrate) Related Product Information
Lanicemine dihydrochloride Buflomedil hydrochloride 4-HYDROXYQUINOLINE-2-CARBOXYLIC ACID, HYDRATE, 98 1-(4-Aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine hydrochloride CHLORMETHIAZOLE HYDROCHLORIDE